NIH head fields grant questions

Written byBob Grant

| 2 min read

NIH is nearing the end of a linkurl:review;http://www.the-scientist.com/article/display/53412/ of the peer review facet of their granting process, and this Friday (Dec. 7) NIH director Elias Zerhouni will linkurl:meet;http://www.the-scientist.com/blog/display/53750/ with his Advisory Committee to the Director to discuss, among other things, the NIH grant peer review process. This afternoon (Dec. 4), Zerhouni took the discussion to the internet in a live chat session with researchers across the nation, hosted on the __The Chronicle of Higher Education__'s linkurl:website.;http://chronicle.com/live/2007/12/zerhouni/chat.php3 The first question Zerhouni tackled was from James O'Rourke of the University of Connecticut Health Center, who asked: "Why cannot more grants for smaller amounts be awarded for innovative start-up projects, to keep alive ideas that need time to show promise?" Zerhouni responded, writing, "We are indeed making more linkurl:grants;http://www.the-scientist.com/blog/display/53456/ for Innovative projects and to keep alive ideas that need time," citing the fact that about 470 scientists were funded by New Innovator Awards, NIH Director Bridge Awards, and Pathway to Independence grants this year. Tim Leshan of Brown University asked Zerhouni about the fate of young researchers seeking NIH support. According to NIH data, only 15 percent of applicants under age 40 received NIH grants in 2006. "What can be done to ensure we don't lose a whole generation of scientists?" wrote Leshan. "We have set a goal of no less than 1523 new investigators to be funded per year which [is] the average of the past five years and we achieved 1608 in 2007," Zerhouni responded. "We need to continue to encourage our early career scientists across the board and we are doing so within the budgetary constraints we have." Later in the discussion, Simo Arredouani of Harvard University returned to the topic of NIH's treatment of young investigators, this time asking the director about postdocs. "How can a postdoc live on $30K/year in a city like Boston for example?" Arredouani asked. "Is there a will at NIH to stop this abuse?" "NIH has increased post docs salaries in the past five years and publishes them as guidelines for institutions," Zerhouni wrote, urging Arredouani to visit the NIH linkurl:website;http://grants.nih.gov/grants/guide/notice-files/NOT-OD-07-057.html where, a starting postdoc salary for 2007 is listed as $36,996. Some questioners probed Zerhouni on the integrity of the peer review itself. Faith Davis of the Ordway Research Institute in Albany, New York, asked, "Why do reviewers not research some of the material they are asked to judge?" suggesting that some reviewers have built-in biases or are not knowledgeable in the materials they review. Zerhouni replied that Davis' comments were some of the most common received by the agency. He then asked her to "stay tuned" as the NIH attempts to improve its granting process.

Meet the Author

Bob Grant

From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

View Full Profile

NIH head fields grant questions

The Scientist ARCHIVES

Become a Member of

Meet the Author

Bob Grant

Related Research Resources

Why Do We Feel Butterflies in the Stomach?

Research Resources

Podcasts

Webinars

Videos

Infographics

eBooks

Long-Read RNA Sequencing Reveals a Regulatory Role for Splicing in Immunotherapy Responses

Research Roundtable: The Evolving World of Spatial Biology

Exploring the State of the Art in Gene Editing Techniques

Simplifying Early Alzheimer’s Disease Diagnosis with Blood Testing

Products

Product News

Research on rewiring neural circuit in fruit flies wins 2025 Eppendorf & Science Prize

EVIDENT's New FLUOVIEW FV5000 Redefines the Boundaries of Confocal and Multiphoton Imaging

EVIDENT Launches Sixth Annual Image of the Year Contest

10x Genomics Launches the Next Generation of Chromium Flex to Empower Scientists to Massively Scale Single Cell Research